To determine whether NFkB is playing a role in the invasive phenotype of ESCC cells, NFkB was inhibited in TE10 and TE11 cells through treatment with either JSH-23 or BAY 11-7085, as described previously. This evidence concerns the gene NFKB1 and esophageal squamous cell carcinoma.